AZD-8055

DB12774InvestigationalSmall molecule

AZD8055 has been used in trials studying the treatment of Cancer, Lymphomas, Solid Tumors, MALIGNANT GLIOMA, and brainstem glioma, among others.

Mechanism: Pharmacologically active on Serine/threonine-protein kinase mTOR
Curator reviewed
Formula / weight: C₂₅H₃₁N₅O₄ · 465.554 g/mol (avg)
Code names: AZD 8055

Resolves to

Compound

Structure

InChIKeyKVLFRAWTRWDEDF-IRXDYDNUSA-NSMILESCOC1=CC=C(C=C1CO)C1=CC=C2C(=N1)N=C(N=C2N1CCOC[C@@H]1C)N1CCOC[C@@H]1C

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

28Drug interactionsStructured to mechanism, not free text

5Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with AZD-8055, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.